摘要
目的观察法莫替丁对慢性阻塞性肺疾病急性加重期胃肠道反应的影响。方法选择2007年8月～2008年10月在我院急诊住院的慢性阻塞性肺疾病急性加重期患者87例,分为观察组和对照组,两组常规治疗相同,观察组加用法莫替丁治疗。比较两组治疗期间发生胃肠道反应的情况。结果观察组44例,发生胃肠道反应2例,对照组43例,发生胃肠道反应8例。计算两组计数资料的χ2值为4.225,P<0.05。结论法莫替丁可有效预防慢性阻塞性肺疾病急性加重期的胃肠道反应。
Objective To study the effect of famotidine preventing gastrointerstinal reaction in chronic obstructive pulmonary disease. Methods 87 patients with chronic obstructive pulmonary disease came from our hospital from August 2007 to Octember 2008. 43 patients as control group treated with routine therapy. Besides routine therapy ,44 patients as experiment group were given famotidine. Results 2 patients happened gastrointerstinal reaction in the experiment group,while 8 patients happened gastrointerstinal reaction in the control group（ χ^2=4.225,P〈0-05）. Conclusion Famotidine can prevent effectively gastrointerstinal reaction of acute exacerbation of chronic obstructive pulmonary disease.
出处
《中国现代医生》
2009年第6期75-75,78,共2页
China Modern Doctor
关键词
法莫替丁
慢性阻塞性肺疾病
胃肠道反应
Famotidine
Chronic obstructive pulmonary disease
Gastrointerstinal reaction
